Longitudinal associations between metabolic syndrome components and telomere shortening

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages 3050-3059

  Révész, Dóra ^a   Milaneschi, Yuri ^a   Verhoeven, Josine E ^a   Lin, Jue ^b   Penninx, Brenda W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TELOMERE SHORTENING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; GENETICS; MIDDLE AGED; NETHERLANDS; PHYSIOLOGY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; RISK FACTORS; TELOMERE SHORTENING; YOUNG ADULT;

EID: 84939212912     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/JC.2015-1995     Document Type: Article

References (56)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002:17;106: 3143-3421.
2. Blackburn EH. Structure and function of telomeres. Nature. 1991; 350:569-573.
3. Olovnikov AM. Telomeres, telomerase, and aging: Origin of the theory. Exp Gerontol. 1996;31:443-448.
4. Blackburn EH. Switching and signaling at the telomere. Cell. 2001; 106:661-673.
5. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007;8:703-713.
6. Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010;464:520-528.
7. Sahin E, Colla S, Liesa M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359-365.
8. Chan SW, Blackburn EH. Telomerase and ATM/Tel1p protect telomeres from nonhomologous end joining. Mol Cell. 2003;11:1379-1187.
9. Broer L, Codd V, Nyholt D, et al. Meta-analysis of telomere length in 19 713 subjects reveals high heritability, stronger maternal inheritance and a paternal age effect. Eur J Hum Genet. 2013;21(10): 1163-1168.
10. O'Donovan A, Pantell MS, Puterman E, et al. Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS One. 2011;6: e19687.
11. Révész D, Verhoeven JE, Milaneschi Y, de Geus EJ, Wolkowitz OM, Penninx BW. Dysregulated physiological stress systems and accelerated cellular aging. Neurobiol Aging. 2014;35:1422-1430.
12. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339-344.
13. Perseguini NM, Verlengia R, Milan JC, et al. Cardiac autonomic modulation, C-reactive protein or telomere length: which of these variables has greater importance to aging? Int J Cardiol. 2015;178: 79-81.
14. Müezzinler A, Zaineddin AK, Brenner H. A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev. 2013; 12:509-519.
15. Willeit P, Raschenberger J, Heydon EE, et al. Leucocyte telomere length and risk of type 2 diabetes mellitus: New prospective cohort study and literature-based meta-analysis. PLoS One. 2014;9: e112483.
16. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ. 2014;349: g4227.
17. D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Paré G. The Association Between shortened leukocyte telomere length and cardio-metabolic outcomes: A Systematic review and meta-analysis. Circ Cardiovasc Genet. 2015;8(1):82-90.
18. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol. 2006;60:174-180.
19. Deelen J, Beekman M, Codd V, et al. Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers. Int J Epidemiol. 2014; 43:878-886.
20. Révész D, Milaneschi Y, Verhoeven J, Penninx B. Telomere length as a marker of cellular ageing is associated with prevalence and progression of metabolic syndrome. J Clin Endocrinol Metab. 2014; jc20141851.
21. Monickaraj F, Aravind S, Gokulakrishnan K, et al. Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem. 2012;365:343-350.
22. Demissie S, Levy D, Benjamin EJ, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006;5:325-330.
23. Harte AL, da Silva NF, Miller MA, et al. Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus. Exp Diabetes Res. 2012;2012:895185.
24. Satoh M, Ishikawa Y, Takahashi Y, Itoh T, Minami Y, Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis. 2008;198:347-353.
25. Zhao J, Zhu Y, Uppal K, et al. Metabolic profiles of biological aging in American Indians: The strong heart family study. Aging (Albany NY). 2014;6:176-186.
26. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116:1234-1241.
27. Huzen J, Wong LS, van Veldhuisen DJ, et al. Telomere length loss due to smoking and metabolic traits. J Intern Med. 2014;275:155-163.
28. Njajou OT, Cawthon RM, Blackburn EH, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2012;36:1176-1179.
29. Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 2005;111: 2171-2173.
30. Garcia-Calzon S, Moleres A, Marcos A, et al. Telomere Length as a Biomarker for Adiposity Changes after a Multidisciplinary Intervention in Overweight/Obese Adolescents: The EVASYON Study. PLoS One. 2014;9:e89828.
31. Garcia-Calzon S, Gea A, Razquin C, et al. Longitudinal association of telomere length and obesity indices in an intervention study with a Mediterranean diet: The PREDIMED-NAVARRA trial. Int J Obes (Lond). 2014;38:177-182.
32. Mason C, Risques RA, Xiao L, et al. Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring). 2013; 21:E549-E554.
33. Penninx BW, Beekman AT, Smit JH, et al. The Netherlands Study of Depression and Anxiety (NESDA): Rationale, objectives and methods. Int J Methods Psychiatr Res. 2008;17:121-140.
34. Verhoeven JE, Révész D, Epel ES, Lin J, Wolkowitz OM, Penninx BW. Major depressive disorder and accelerated cellular aging: Results from a large psychiatric cohort study. Mol Psychiatry. 2014; 19:895-901.
35. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e4715.
36. Licht CM, Vreeburg SA, van Reedt Dortland AK, et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 2010; 95:2458-2466.
37. Licht CM, de Geus EJ, Penninx BW. Dysregulation of the autonomic nervous system predicts the development of the Metabolic Syndrome. J Clin Endocrinol Metab 2013;98:2484-2493.
38. van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand. 2010;122:30-39.
39. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care. 2013;36(Suppl 1):S11-S66.
40. Packard CJ. Overview of fenofibrate. Eur Heart J. 1998;19(Suppl A):A62-A65.
41. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: A meta-analysis. J Hypertens. 2004;22:435-445.
42. Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-1395.
43. Verhoeven JE, Révész D, van Oppen P, Epel ES, Wolkowitz OM, Penninx BW. Anxiety Disorders and Accelerated Cellular Aging. Br J Psychiatry. 2014;206(5):371-378.
44. Weischer M, Bojesen SE, Nordestgaard BG. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart. PLoS Genet. 2014;10:e1004191.
45. Cotillard A, Poitou C, Torcivia A, et al. Adipocyte size threshold matters: Link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab. 2014;99: E1466-E1470.
46. Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277-287.
47. Marseglia L, Manti S, D'Angelo G, et al. Oxidative stress in obesity: A critical component in human diseases. Int J Mol Sci. 2014;16: 378-400.
48. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: The paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367-373.
49. Monickaraj F, Gokulakrishnan K, Prabu P, et al. Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia in obese subjects and in patients with type 2 diabetes. Clin Biochem. 2012;45:1432-1438.
50. Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol. 2007;36:220-225.
51. Bergman RN, Kim SP, Catalano KJ, et al. Why visceral fat is bad: Mechanisms of the metabolic syndrome. Obesity (Silver Spring). 2006;14(Suppl 1):16S-19S.
52. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010-1013.
53. Effros RB. Kleemeier Award Lecture 2008 - The canary in the coal mine: Telomeres and human healthspan. J Gerontol A Biol Sci Med Sci. 2009;64:511-515.
54. Lin J, Epel E, Cheon J, et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. J Immunol Methods. 2010; 352:71-80.
55. Lin Y, Damjanovic A, Metter EJ, et al. Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions. Clin Sci (Lond). 2015;128:367-377.
56. Aubert G, Hills M, Lansdorp PM. Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat Res. 2012;730:59-67.